Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
Thirty-eight of 295 subjects participating in a randomized, double-blind, placebo-controlled trial of the efficacy of daily administration of atovaquone/proguanil for malaria prevention developed malaria at some time during the 20-week prophylaxis period. These subjects (3 atovaquone/proguanil recip...
Hlavní autoři: | Lacy, MD, Maguire, J, Barcus, M, Ling, J, Bangs, M, Gramzinski, R, Basri, H, Sismadi, P, Miller, G, Chulay, J, Fryauff, D, Hoffman, S, Baird, J |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2002
|
Podobné jednotky
-
Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Autor: Ling, J, a další
Vydáno: (2002) -
Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua.
Autor: Barcus, M, a další
Vydáno: (2003) -
Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports.
Autor: Färnert, A, a další
Vydáno: (2003) -
Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
Autor: McKeage, K, a další
Vydáno: (2003) -
Inhibition of the mosquito transmission of Plasmodium berghei by Malarone (atovaquone-proguanil).
Autor: Butcher, G, a další
Vydáno: (2000)